From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I
…, JJ Badimon, C Stefanadis, P Moreno, G Pasterkamp… - Circulation, 2003 - Am Heart Assoc
Atherosclerotic cardiovascular disease results in >19 million deaths annually, and coronary
heart disease accounts for the majority of this toll. Despite major advances in treatment of …
heart disease accounts for the majority of this toll. Despite major advances in treatment of …
[PDF][PDF] Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the …
…, U Laufs, L Masana, G Pasterkamp… - European heart …, 2020 - academic.oup.com
OP-EHEA191011_online 2313..2340 Page 1 Low-density lipoproteins cause atherosclerotic
cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus …
cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus …
Microanatomy of the human atherosclerotic plaque by single-cell transcriptomics
…, J Kuiper, MPJ De Winther, G Pasterkamp - Circulation …, 2020 - Am Heart Assoc
Rationale: Atherosclerotic lesions are known for their cellular heterogeneity, yet the molecular
complexity within the cells of human plaques has not been fully assessed. Objective: …
complexity within the cells of human plaques has not been fully assessed. Objective: …
[HTML][HTML] Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury
…, L Timmers, CN Lee, RM El Oakley, G Pasterkamp… - Stem cell …, 2010 - Elsevier
Human ESC-derived mesenchymal stem cell (MSC)-conditioned medium (CM) was previously
shown to mediate cardioprotection during myocardial ischemia/reperfusion injury through …
shown to mediate cardioprotection during myocardial ischemia/reperfusion injury through …
[HTML][HTML] Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and …
…, HV van Rijen, PA Doevendans, G Pasterkamp… - Stem cell …, 2013 - Elsevier
We have previously identified exosomes as the paracrine factor secreted by mesenchymal
stem cells. Recently, we found that the key features of reperfusion injury, namely loss of ATP/…
stem cells. Recently, we found that the key features of reperfusion injury, namely loss of ATP/…
Extracellular vesicles for drug delivery
P Vader, EA Mol, G Pasterkamp… - Advanced drug delivery …, 2016 - Elsevier
Extracellular vesicles (EVs) are cell-derived membrane vesicles, and represent an endogenous
mechanism for intercellular communication. Since the discovery that EVs are capable of …
mechanism for intercellular communication. Since the discovery that EVs are capable of …
Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses
…, M Mills, R de Mutsert, AJ Oldehinkel, G Pasterkamp… - Nature …, 2016 - nature.com
Very few genetic variants have been associated with depression and neuroticism, likely
because of limitations on sample size in previous studies. Subjective well-being, a phenotype …
because of limitations on sample size in previous studies. Subjective well-being, a phenotype …
[HTML][HTML] Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium
…, RM El Oakley, A Choo, CN Lee, G Pasterkamp… - Stem cell …, 2008 - Elsevier
Although paracrine effects of mesenchymal stem cells (MSCs) have been suggested previously,
cardioprotection by human MSC secretions has never been demonstrated. Human MSC…
cardioprotection by human MSC secretions has never been demonstrated. Human MSC…
Arterial remodeling: mechanisms and clinical implications
MR Ward, G Pasterkamp, AC Yeung, C Borst - Circulation, 2000 - Am Heart Assoc
In normal arteries, remodeling is a homeostatic response to changes in the flow and
circumferential stretch to restore normal shear stress and wall tension, respectively. 12 Outward …
circumferential stretch to restore normal shear stress and wall tension, respectively. 12 Outward …
Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury
…, JJ Piek, PA Doevendans, G Pasterkamp… - Journal of the American …, 2009 - jacc.org
Objectives : This study sought to examine whether exenatide is capable of reducing myocardial
infarct size. Background : Exenatide is a glucagon-like peptide (GLP)-1 analogue with …
infarct size. Background : Exenatide is a glucagon-like peptide (GLP)-1 analogue with …